Concepedia

Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series

Christoph Oing, Marcus Hentrich, Anja Lorch, Dietrich Gläser, Holger Rumpold, Sebastian Ochsenreither, Stephan Richter, Annette Dieing, Stefanie Zschäbitz, Ronnie Rodrigues Pereira,

Journal of Cancer Research and Clinical Oncology · 2019 · 11 citations · 5 references

DOIFull text

Open access

Concepts

References

5

Guidelines on Testicular Cancer: 2015 Update

Peter Albers, Walter Albrecht, Ferrán Algaba et al. · European Urology · 2015 · 674 citations

, , +12

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

Journal of Clinical Oncology · 2010 · 316 citations

, , +16

Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group

Carsten Bokemeyer, Karin Oechsle, Friedemann Honecker et al. · Annals of Oncology · 2007 · 127 citations

, , +10

Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care—Registry data from an outcomes research project of the German Testicular Cancer Study Group

Christoph Seidel, Karin Oechsle, Anja Lorch et al. · Urologic Oncology Seminars and Original Investigations · 2015 · 36 citations

, , +9

Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells

Mirjam Gerwing, Christine Jacobsen, Sergey A. Dyshlovoy et al. · Journal of Cancer Research and Clinical Oncology · 2016 · 13 citations · Full text

, , +14